Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration Award
Forecasted
This grant funds collaborative, innovative projects at academic medical centers to speed up turning scientific discoveries into real-world treatments and health solutions.
Browse similar grants
Funder: National Institutes of Health
Due Dates (Anticipated): February 2027 (Full application deadline, projected)
Funding Amounts: Award size and total funding not specified; cooperative agreement mechanism; duration and ceiling TBD in full NOFO.
Summary: Supports collaborative, innovative projects that accelerate translational science and enhance the impact of the CTSA Program network.
Key Information: Limited competition—only prior CTSA UM1 awardees or partners are eligible.
Description
This opportunity, under the Clinical and Translational Science Awards (CTSA) Program, is a limited competition forecasted award designed to accelerate the translation of scientific discoveries into treatments, diagnostics, and health interventions. The Collaborative and Innovative Acceleration Award will support the development of innovative approaches, technologies, or models that enhance research impact, advance translational science, and expedite the delivery of treatments to diverse populations. The program emphasizes collaboration across the CTSA network and aims to bring more effective health solutions to patients and communities more rapidly.
